0001209191-23-020682.txt : 20230322 0001209191-23-020682.hdr.sgml : 20230322 20230322205243 ACCESSION NUMBER: 0001209191-23-020682 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230320 FILED AS OF DATE: 20230322 DATE AS OF CHANGE: 20230322 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WILSON ROBERT N CENTRAL INDEX KEY: 0001189022 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39538 FILM NUMBER: 23754271 MAIL ADDRESS: STREET 1: C/O JOHNSON & JOHNSON STREET 2: ONE JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CalciMedica, Inc. /DE/ CENTRAL INDEX KEY: 0001534133 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452120079 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 COAST BOULEVARD SOUTH STREET 2: SUITE 307 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-952-5500 MAIL ADDRESS: STREET 1: 505 COAST BOULEVARD SOUTH STREET 2: SUITE 307 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: GRAYBUG VISION, INC. DATE OF NAME CHANGE: 20170717 FORMER COMPANY: FORMER CONFORMED NAME: GRAYBUG, Inc. DATE OF NAME CHANGE: 20150303 FORMER COMPANY: FORMER CONFORMED NAME: GRAYBUG LLC DATE OF NAME CHANGE: 20111102 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-03-20 0 0001534133 CalciMedica, Inc. /DE/ CALC 0001189022 WILSON ROBERT N C/O CALCIMEDICA, INC. 505 COAST S. BLVD. #202 LA JOLLA CA 1 0 0 0 0 Common Stock 2023-03-20 4 A 0 181655 A 181655 D Director Stock Option (right to buy) 6.60 2023-03-20 4 A 0 23557 A 2030-06-29 Common Stock 23557 23557 D Director Stock Option (right to buy) 7.99 2023-03-20 4 A 0 5760 A 2031-04-27 Common Stock 5760 5760 D Director Stock Option (right to buy) 7.99 2023-03-20 4 A 0 5760 A 2031-06-30 Common Stock 5760 5760 D Director Stock Option (right to buy) 17.34 2023-03-20 4 A 0 7577 A 2033-03-19 Common Stock 7577 7577 D Director Stock Option (right to buy) 17.34 2023-03-20 4 A 0 1488 A 2033-03-19 Common Stock 1488 1488 D Warrant 27.94 2023-03-20 4 A 0 8592 A 2026-02-22 Common Stock 8592 8592 D Warrant 27.94 2023-03-20 4 A 0 8592 A 2026-06-25 Common Stock 8592 8592 D Received in exchange for 6,307,451 shares of common stock of CalciMedica, Inc. ("CalciMedica") pursuant to an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among CalciMedica, the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"). Under the terms of the Merger Agreement, on March 20, 2023, Merger Sub merged with and into CalciMedica (the "Merger"), with CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. Beginning on June 15, 2020, the shares subject to the option vest in a series of forty-eight (48) successive equal monthly installments. Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. Received in exchange for a stock option to acquire 817,964 shares of common stock of CalciMedica pursuant to the Merger Agreement. Beginning on November 22, 2022, the shares subject to the option vest in a series of twelve (12) successive equal monthly installments. Beginning on February 22, 2021, the shares subject to the option vest in a series of forty-eight (48) successive equal monthly installments. Received in exchange for a stock option to acquire 200,000 shares of common stock of CalciMedica pursuant to the Merger Agreement. Received in exchange for a stock option to acquire 263,107 shares of common stock of CalciMedica pursuant to the Merger Agreement. Received in exchange for a stock option to acquire 51,692 shares of common stock of CalciMedica pursuant to the Merger Agreement. Immediately exercisable. Received in exchange for a warrant to purchase 298,321 shares of common stock of CalciMedica pursuant to the Merger Agreement. By John Dunn, Attorney-in-Fact 2023-03-22